WASHINGTON, April 5 (UPI) -- A vaccine protecting against two types of viruses that cause cervical cancer has demonstrated unusual staying power, new research shows.
"This is the most significant advance in cancer prevention in the last 50 years," said lead author Diane Harper, director of Gynaecologic Cancer Prevention Research at Dartmouth Medical School. "We now have a vaccine that's 100 percent effective," she added.